LGALS3 and neoplasm: Our results suggest that Galectin-3 downregulation in tumors during the course of cancer progression, invasion, and further metastasis is intrinsically associated with ECM remodeling, which favors Gal-3-mediated detachment of tumor cells to the primary site via regulation of GAGs.